You searched for "genes"
ENT in this issue...Women in Leadership
Sujana S Chandrasekhar, MD, Past President, AAO-HNS/F; Secretary-Treasurer, American Otological Society; Consulting Editor, Otolaryngologic Clinics of North America; Recipient, AAO-HNS WIO Helen Krause Trailblazer Award and AMA Physician Mentor Recognition Award. Emma Stapleton Consultant Otolaryngologist, Cochlear Implant and Skull Base...4th Annual Inner Ear Disorders Therapeutics Summit
Terrri Gaskell, Chief Technology Officer, Rinri TherapueticsHeld in Boston, USA, this was an essential gathering that captured the growing excitement in both the biotech and clinical communities surrounding the rapid advancements in hearing loss therapies. With the potential to significantly...
Vestibular functions of hereditary hearing loss patients with GJB2 mutations
Mutations of the GJB2 gene are a common cause of deafness, being found in 15-25% of cases of congenital deafness. Over 100 mutations are now recognised and may be associated with a hearing loss ranging from mild to profound. This...
A higher aspiration for fine needles
Fine needle aspiration biopsy (FNAB) has aided in the diagnosis and management of thyroid nodules for decades. Now a rapid evolution is hoped to benefit an increasing cohort of patients with small nodules and non-diagnostic investigations. This review discusses the...
Those little friends in our noses
Human microbiota plays an important role in both health and disease including metabolism, immunomodulation, and a potential role in chronic inflammatory conditions such as chronic rhinosinusitis (CRS). The authors aimed to investigate the sinonasal microbiome using 16S rRNA gene sequencing...
Age and sleep disorders as risk factors for Ménière’s disease
Decades after it was first described, the pathophysiology of Ménière’s disease is still a subject for research and discussion, with several controversies regarding its management. Several factors have been reported to cause Ménière’s disease including viral infections, allergies, genetic factors,...BAPO Annual Meeting 2025
BAPO’s flagship annual meeting returns for 2025 in Glasgow!Haytham Kubba extends his warm invitation to this exciting gathering, where Professor Natalie Loundon from Hôpital Necker-Enfants Malades, Paris, will deliver the prestigious John Evans Lecture on gene therapy in paediatric hearing...5th Annual Inner Ear Disorders Therapeutics Summit
Coined by industry as the only meeting of its kind and uniquely positioned to share fresh ideas and assess viable approaches to your most pressing preclinical, translational, and clinical bottlenecks, the 5th Inner Ear Disorders Summit returns as a forum to benchmark learnings from past failures, reignite momentum and develop investment into the audiology therapeutic landscape.Systemic agents in thyroid cancer
For those patients who have disseminated or unresectable thyroid cancer, Dr Arabella Hunt and Dr Kate Newbold review systemic treatments, their differences, toxicities and outcomes. Thyroid cancer is the most common endocrine malignancy. It is subdivided into differentiated (papillary, follicular...Cochlear implantation in the developing world: perspectives from the Indian subcontinent
Cochlear implants are an expensive technology, yet profound hearing loss is far from a developed-world phenomenon. On the contrary, incidences of both congenital and acquired hearing losses are high in the developing world. This article explains how an initiative in...COVID-19: UCT-Africa Virtual ENT transcends academic silos
The COVID-19 pandemic has been a global catastrophe with far-reaching consequences felt across many fronts around the world. One such aspect is the training of the future generation of ENT surgeons. With routine elective activity curtailed, academic conferences cancelled, and...
